Madison Avenue Partners’s Indivior Pharmaceuticals INDV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132M	Sell	4,315,162 -1,965,340	-31%	-$64.9M	5.72%	8
2025 Q4	$225M	Sell	6,280,502 -183,083	-3%	-$5.59M	9.68%	4
2025 Q3	$156M	Sell	6,463,585 -1,458,593	-18%	-$30.5M	9.3%	4
2025 Q2	$117M	Buy	7,922,178 +130,089	+2%	+$1.52M	7.8%	5
2025 Q1	$74.3M	Buy	7,792,089 +4,118,663	+112%	+$43.3M	6.3%	6
2024 Q4	$45.7M	Sell	3,673,426 -287,346	-7%	-$2.96M	4.84%	9
2024 Q3	$38.6M	Buy	3,960,772 +3,737,340	+1,673%	+$43.8M	3.58%	9
2024 Q2	$3.6M	Buy	223,432 +60,537	+37%	+$1.09M	0.46%	16
2024 Q1	$3.49M	Buy	162,895 +90,640	+125%	+$1.7M	0.56%	17
2023 Q4	$1.1M	Buy	72,255 +33,168	+85%	+$589K	0.16%	17
2023 Q3	$902K	Buy	39,087 +27,887	+249%	+$636K	0.13%	18
2023 Q2	$267K	Buy	+11,200	New	+$257K	0.06%	19